Trials / Completed
CompletedNCT00646737
Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant
Phase IV Study of Enteric-coated Mycophenolate Sodium in Combination With Tacrolimus in Renal Transplant Patient
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and the tolerability of the substitution of mycophenolate mofetil for enteric-coated mycophenolate sodium in a population of stable renal transplant patients in Brazil, in a treatment regimen of immunosuppressants with tacrolimus and mycophenolate mofetil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mycophenolate sodium | Mycophenolate sodium |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-03-28
- Last updated
- 2017-02-23
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00646737. Inclusion in this directory is not an endorsement.